# Antiplatelet Therapy After Cardiac Arrest

> **NCT02224274** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 57 (actual)

## Conditions studied

- Cardiac Arrest
- Postresuscitation Syndrome
- Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02224274
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02224274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02224274, "Antiplatelet Therapy After Cardiac Arrest". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02224274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*